NCT06040281 Smart and Fit for Kidney Transplantation
| NCT ID | NCT06040281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Erlangen-Nürnberg Medical School |
| Condition | Chronic Kidney Disease Requiring Chronic Dialysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-09-18 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-09-18 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised controlled intervention trial for patients with chronic kidney disease who are on the waiting list for a kidney transplantation (n=200). The aim of this study is to test the effectiveness of intensive individual nutritional and exercise support combined with comprehensive rehabilitation before transplantation in comparison to a control group.
Eligibility Criteria
Inclusion Criteria: * Patients must be on dialysis * Patients ≥ 18 years of age * Patients who own a smartphone * Patients must be willing to undergo inpatient rehabilitation within the project period * signed informed consent and data protection regulation Exclusion Criteria: * Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers * Patients who have already participated in a similar project
Contact & Investigator
Mario Schiffer, Prof.
STUDY DIRECTOR
Universitätsklinikum Erlangen
Frequently Asked Questions
Who can join the NCT06040281 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Disease Requiring Chronic Dialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06040281 currently recruiting?
Yes, NCT06040281 is actively recruiting participants. Contact the research team at helge.krusemark@uk-erlangen.de for enrollment information.
Where is the NCT06040281 trial being conducted?
This trial is being conducted at Erlangen, Germany.
Who is sponsoring the NCT06040281 clinical trial?
NCT06040281 is sponsored by University of Erlangen-Nürnberg Medical School. The principal investigator is Mario Schiffer, Prof. at Universitätsklinikum Erlangen. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.